Guidelines for the diagnosis and treatment of obstructive sleep apnea in adults (2025)
Abstract
Obstructive sleep apnea (OSA) is a highly prevalent sleep-related breathing disorder with a considerable healthcare burden. Previously, the 2011 guideline for adult obstructive sleep apnea was largely formulated on the basis of expert opinion and consensus, which played an important role in guiding clinical practice. With the growing body of evidence from high-quality clinical studies, however, guideline development models that rely primarily on expert consensus are no longer adequate to support contemporary clinical decision-making. To further standardize the screening, diagnosis, treatment, and long-term management of OSA in adults, the Sleep Disordered Breathing Assembly of the Chinese Thoracic Society has developed evidence-based clinical practice guidelines. The recommendations were formulated according to the best currently available evidence, following the Appraisal of Guidelines for Research and Evaluation Ⅱ (AGREE Ⅱ) framework and the Reporting Items for Practice Guidelines in Healthcare (RIGHT) statement. Based on an extensive preliminary investigation, the guideline addresses 18 key clinical questions and provides detailed, evidence-based recommendations, aiming to support clinical decision-making and to promote standardized diagnosis, treatment, and management of adults with OSA in China.The clinical questions and recommendations are listed below.Question 1: Which populations should be screened for OSA?Recommendation 1: Routine screening for OSA is not…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.